On Nov. 10, a verified Twitter account posed as Eli Lilly wrote in a viral tweet, “We are excited to announce insulin is free now.” By the next day, the drugmaker’s shares plunged by about $22 billion.
Read the full post on Becker's Hospital Review - Healthcare News
